LSBio The Immunohistochemistry Antibody Company
  • Home
  • Products
    • All Antibodies
    • IHC-plus Antibodies
  • Services
    • Immunohistochemistry Studies
    • Tissue Cross-Reactivity Screening
  • Distributors
  • Resources
    • About our Tissue Bank
    • Customer Support
    • How to Buy
    • IHC-plus Protocol
    • LSBio Media
    • Publications
    • Antibody Reports
  • Company
    • About LifeSpan
    • Press Releases
    • Holiday Schedule
    • Contact Us
  • View Cart

Bladder Cancer Screen 18 Tissue Microarray - LS-SBLCA18

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Catalog ID: LS-SBLCA18
Product Name: Bladder Cancer Screen 18
Description: Various bladder diseases (urocystic cancer progression)
Format: FFPE
Category: Human Tumor Progression
QA/QC: H&E reviewed
Storage: Short term RT; Long term 4ºC
Clinical History: No
Tissue Marker: No
Stage/Grade: Yes
Core Diameter: 1.5 mm
Core Thickness: 5 µm
Cases: 80
Cores: 80
Slides Per Set: 1

LS-SBLCA18 Tissue Microarray Map

Slide Number 1
LABEL
 12345678910
ABlaBlaBlaBlaBlaBlaBlaBlaBlaBla
BBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
CBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
DBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
EBlaAbdAbdBrnBlaBlaBlaBlaBlaBla
FBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
GBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
HBlaBlaBlaBlaBlaBlaBlaBlaBlaBla
Diagnosis Type Legend
Benign non-neoplasticDiseasedInflammatoryMalignantMetastaticTumorUnknown
Element Tissue Legend
Abdomen (Abd); Bladder (Bla); Bladder, Fibrous tissue and smooth muscle (Bla); Bladder, Mucosa (Bla); Bladder, Mucosa, Fibrous tissue (Bla); Bladder, Mucosa, Fibrous tissue and blood vessel (Bla); Bladder, Mucosa, Fibrous tissue and smooth muscle (Bla); Brain, Cerebrum (Brn);

LS-SBLCA18 Element Details

SlidePositionSpeciesGenderAgeTissueDiagnosisDiagnosis TypeTNM Tumor ClassificationTumor GradeTumor StageTumor Differentiation
1A1HumanM63 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M01II
1A2HumanM57 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M01I
1A3HumanF45 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M02I
1A4HumanM72 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1A5HumanM43 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M02I
1A6HumanF56 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M02I
1A7HumanF54 yBladder (Bla)Transitional cell carcinomaMalignant2
1A8HumanM66 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M02I
1A9HumanM60 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M02I
1A10HumanF79 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M02II
1B1HumanM45 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1B2HumanM66 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M02II
1B3HumanM45 yBladder (Bla)Transitional cell carcinomaMalignantT3bN0M02III
1B4HumanM65 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1B5HumanM65 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1B6HumanM69 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M02I
1B7HumanF64 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M02II
1B8HumanF58 yBladder (Bla)Transitional cell carcinomaMalignantT2bN0M02II
1B9HumanM50 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1B10HumanF47 yBladder (Bla)Transitional cell carcinomaMalignantT2bN0M02II
1C1HumanM38 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M01I
1C2HumanM45 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M01I
1C3HumanM42 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1C4HumanM68 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M02II
1C5HumanM70 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M02II
1C6HumanM65 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M02II
1C7HumanM68 yBladder (Bla)Transitional cell carcinomaMalignantT2aN0M03II
1C8HumanM58 yBladder (Bla)Transitional cell carcinomaMalignantT2N0M03II
1C9HumanM49 yBladder (Bla)Transitional cell carcinomaMalignantT1N0M03I
1C10HumanF48 yBladder (Bla)Transitional cell carcinomaMalignantT2bN0M03II
1D1HumanM73 yBladder (Bla)Squamous cell carcinomaMalignantT2N0M01II
1D2HumanM51 yBladder (Bla)Squamous cell carcinomaMalignantT3aN0M01II
1D3HumanM74 yBladder (Bla)Squamous cell carcinomaMalignantT2aN0M01II
1D4HumanM68 yBladder (Bla)Squamous cell carcinomaMalignantT3aN0M01II
1D5HumanM67 yBladder (Bla)Squamous cell carcinomaMalignantT3aN0M02II
1D6HumanM66 yBladder, Fibrous tissue and smooth muscle (Bla)AdenocarcinomaMalignantT3bN0M0III
1D7HumanM69 yBladder (Bla)Adenocarcinoma with necrosisMalignantT3bN0M02-3III
1D8HumanM68 yBladder (Bla)CarcinomaMalignantT3bN0M0IIIUndifferentiated
1D9HumanM54 yBladder (Bla)Carcinoma sarcomatodesMalignantT3aN0M0II
1D10HumanM53 yBladder (Bla)Carcinoma sarcomatodesMalignantT3bN0M0III
1E1HumanF74 yBladder (Bla)Carcinoma sarcomatodesMalignantT3bN0M0III
1E2HumanM63 yAbdomen (Abd)Metastasis from bladder transitional cell carcinomaMetastatic2
1E3HumanF51 yAbdomen (Abd)Metastasis from bladder transitional cell carcinomaMetastatic2
1E4HumanM61 yBrain, Cerebrum (Brn)Metastasis from transitional cell carcinomaMetastatic3
1E5HumanM48 yBladder (Bla)Transitional cell carcinoma, PapillaryMalignant    
1E6HumanM68 yBladder (Bla)Transitional cell carcinoma, PapillaryMalignant    
1E7HumanM64 yBladder (Bla)Transitional cell carcinoma, PapillaryMalignant    
1E8HumanM67 yBladder (Bla)PheochromocytomaTumor    
1E9HumanF37 yBladder (Bla)PheochromocytomaTumor    
1E10HumanM69 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F1HumanM58 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F2HumanM43 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F3HumanM50 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F4HumanM68 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F5HumanM54 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F6HumanM33 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F7HumanM47 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F8HumanM65 yBladder, Mucosa (Bla)HyperplasiaDiseased    
1F9HumanM44 yBladder, Mucosa, Fibrous tissue and blood vessel (Bla)HyperplasiaDiseased    
1F10HumanM62 yBladder (Bla)Focal neoplasiaTumor    
1G1HumanM55 yBladder, Mucosa (Bla)Hyperplasia, AdenoidDiseased    
1G2HumanM64 yBladder, Mucosa, Fibrous tissue (Bla)Inflammation, ChronicInflammatory    
1G3HumanF48 yBladder, Mucosa, Fibrous tissue and smooth muscle (Bla)Inflammation, ChronicInflammatory    
1G4HumanF71 yBladder, Mucosa, Fibrous tissue and smooth muscle (Bla)Inflammation, ChronicInflammatory    
1G5HumanM55 yBladder, Mucosa (Bla)Inflammation, Chronic with squamous metaplasiaInflammatory    
1G6HumanM36 yBladder, Mucosa (Bla)Inflammation, ChronicInflammatory    
1G7HumanM54 yBladder, Mucosa (Bla)Inflammation, ChronicInflammatory    
1G8HumanF75 yBladder, Mucosa (Bla)Inflammation, ChronicInflammatory    
1G9HumanF72 yBladder, Mucosa (Bla)Inflammation, ChronicInflammatory    
1G10HumanM5 moBladder, Mucosa (Bla)Adjacent normal with cystitisDiseased    
1H1HumanM35 yBladder, Fibrous tissue and smooth muscle (Bla)Adjacent normalBenign non-neoplastic    
1H2HumanM50 yBladder (Bla)Adjacent normalBenign non-neoplastic    
1H3HumanM22 yBladder (Bla)Adjacent normalBenign non-neoplastic    
1H4HumanF40 yBladder, Fibrous tissue and smooth muscle (Bla)Adjacent normalBenign non-neoplastic    
1H5HumanF15 yBladder (Bla)NormalBenign non-neoplastic    
1H6HumanF18 yBladder (Bla)NormalBenign non-neoplastic    
1H7HumanM43 yBladder (Bla)NormalBenign non-neoplastic    
1H8HumanF21 yBladder, Fibrous tissue and smooth muscle (Bla)NormalBenign non-neoplastic    
1H9HumanF21 yBladder (Bla)NormalBenign non-neoplastic    
1H10HumanF41 yBladder (Bla)NormalBenign non-neoplastic    
PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.

Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved